Delivery Order SPE2DR25D1004-SPE2DR26FSTY3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,103.21 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 60 mg on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,389.28 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 90 mg on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitive award, issued on a firm fixed price basis with no set-aside designation, represents a single delivery order fulfillment for pharmaceutical supply to support federal medical procurement needs. The vendor, headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.64 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 90 mg on June 20, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the awardee's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Armour Thyroid 90 mg tablets in a quantity of 100 units, valued at $2,122.76. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a $1,418.43 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 120 mg, with a completion date of May 1, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.11 to AmerisourceBergen Drug Corp for Armour Thyroid 60 mg tablets (100-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,325.33 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 90 mg on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $576.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 30mg tablets of Armour Thyroid. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will fulfill the order from its place of performance in Conshohocken, Pennsylvania by the scheduled completion date of August 4, 2023. The Defense Logistics Agency supports Department of Defense procurement programs by...
- This delivery order, valued at $1,958.68, was awarded on October 24, 2025, to AmerisourceBergen Drug Corp for the supply of Armour Thyroid 120 mg tablets (100-count units) to support federal medical procurement needs. The contract is non-set-aside and competitively awarded, utilizing firm fixed pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for the Defense Logistics Agency (DLA), which funds...
- The Defense Logistics Agency Troop Support Medical awarded a $1,216.83 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 60 mg Armour Thyroid medication. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The delivery order was awarded on August 25, 2023 under an indefinite-delivery/indefinite-quantity contract vehicle and has an end date of August 28, 2023. No subcontractors or set aside designations were...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSTY3Delivery Order
The Defense Logistics Agency awarded a $1,033.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 30 mg on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order represents a small-value transaction within AmerisourceBergen's extensive portfolio of pharmaceutical procurement for federal military and veteran healthcare systems. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company has demonstrated significant capability to meet federal requirements through competitive procurement across a comprehensive range of therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for thyroid hormone replacement therapy supports the broader mission of the DLA Medical Supply Chain to provide essential pharmaceutical products to military personnel and veteran populations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/24/25 |